Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Fluorouracil-dextran and process for preparing the same

A technology of fluorouracil and dextran, which is applied in the field of anti-tumor macromolecule prodrug-fluorouracil-dextran conjugate and preparation thereof

Inactive Publication Date: 2006-02-15
SHENYANG PHARMA UNIVERSITY
View PDF1 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Synthesis of fluorouracil dextran polymer prodrugs using this connection method has not been reported in the literature

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fluorouracil-dextran and process for preparing the same
  • Fluorouracil-dextran and process for preparing the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] 1. Synthesis of fluorouracil-1-acetic acid

[0027] Dissolve 13.0g of fluorouracil in 75ml of water containing 11.2g of potassium hydroxide, add 40ml of aqueous solution containing 9.5g of chloroacetic acid, adjust the pH value to greater than 10 with potassium hydroxide, heat up and reflux for 2 hours, cool to room temperature, and acidify with concentrated hydrochloric acid , a precipitate was obtained, filtered, and recrystallized with water to obtain 8.0 g, yield 50%.

[0028] 2. Synthesis of fluorouracil-dextran

[0029] 1g (6.17mmol of anhydrous glucose unit) dextran was dissolved in 20ml of mixed solvent (formamide: dimethylformamide: dichloromethane = 10:9:1 (v / v / v)), kept at 30°C, added fluorouracil - 1.16g (6.17mmol) of 1-acetic acid, after dissolving, add 75mg DMAP, stir to dissolve, add 1.27g (6.17mmol) of dicyclohexylcarbodiimide, and keep warm at 30°C for 24 hours. Remove the generated dicyclohexylurea by filtration, pour the filtrate into 160ml of metha...

Embodiment 2

[0031] Synthesis of Fluorouracil-Dextran Conjugates

[0032]Dissolve 1g of carbonyldiimidazole in tetrahydrofuran, add 1.16g of fluorouracil-1-acetic acid at room temperature, stir for 4 hours, evaporate the solvent under reduced pressure, dissolve the solid in 20ml of DMSO, add an appropriate amount of triethylamine, and then add 1g (6.17mmol Water glucose unit) dextran is dissolved in the solution of DMSO of 20ml, keep warm at 30 ℃, react for 24 hours. The reaction solution was poured into 160ml of methanol:ether (3:1, v / v) mixed solvent to precipitate, collected by filtration, washed successively with 50ml of ether and 50ml of acetone, dried at 30°C in the presence of phosphorus pentoxide, and kept dry stored in the device.

Embodiment 3

[0034] In vitro stability of fluorouracil-dextran conjugates

[0035] Prepare hydrochloric acid, citrate, acetate, phosphate and borate buffers with a concentration of 0.1M and pH values ​​of 1.24, 2.96, 4.95, 6.80, and 8.75, and add an appropriate amount of NaCl to adjust the total ions of each buffer The strength is 0.5M. Take 9.5ml of each of the above solutions, put them on a constant temperature water bath at 60°C, preheat for 30min, add 0.5ml of FT-70 aqueous solution of appropriate concentration (FUAC substitution degree is 15.1%), so that the final FUAC (calculated by FUAC) concentration is 50μM, respectively 200 μl samples were taken at different time points, and the contents of FUAC and Fu were analyzed by high performance liquid chromatography. The hydrolysis constants of the conjugates in different buffers were calculated from the contents of FUAC and Fu in the reaction solution at different times.

[0036] It can be seen from the test results that the precursor ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a fluorouracil-dextran conjugate and its preparing process, which comprises, derivatizing fluorouracil, introducing acetic acid groups onto the N1 position of fluorouracil, carrying out esterification reaction by utilizing the hydroxyl on the carboxyl and the dextran, thus obtaining fluorouracil-dextran macromolecular precursor medicament.

Description

Technical field: [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to an anti-tumor polymer prodrug-fluorouracil-dextran conjugate and a preparation method thereof. Background technique: [0002] Fluorouracil is an anti-metabolite anti-tumor drug, which exerts anti-tumor effects by inhibiting thymidylate synthase (TS) and misincorporating into RNA to cause lethal synthesis of proteins. It is characterized by a short half-life in vivo (about 15 minutes), and the curative effect of a single injection is not as good as that of an intravenous infusion. In addition, at low concentrations, fluorouracil can exert anti-tumor effects by inhibiting the polyadenylic acid synthesis of m-RNA. Therefore, it is more suitable for preparing sustained-release preparations. However, fluorouracil has relatively large toxic and side effects in clinical practice. A large number of researches have been carried out on the dosage forms of fluorouraci...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/48A61K47/36A61K31/513A61P35/00C08B37/02A61K47/54
Inventor 郝爱军邓英杰
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com